Business Description
Bone Biologics Corp
NAICS : 325412
SIC : 3842
ISIN : US0980702049
Description
Bone Biologics Corp is a healthcare solutions provider based in the United States. As a biotechnology firm, it engages its efforts in developing therapeutics to aid bone regeneration. The company's portfolio comprises its lead product, NELL-1, which is a bone void filler. Bone Biologics' technology has applications in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.93 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 19.5 | |||||
| 3-Year EPS without NRI Growth Rate | 38.1 | |||||
| 3-Year FCF Growth Rate | -0.7 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 61.88 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 45.46 | |||||
| 9-Day RSI | 45.53 | |||||
| 14-Day RSI | 43.82 | |||||
| 6-1 Month Momentum % | 8.77 | |||||
| 12-1 Month Momentum % | -73.1 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 14.89 | |||||
| Quick Ratio | 14.89 | |||||
| Cash Ratio | 13.06 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -118.6 | |||||
| Shareholder Yield % | -59.85 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -121.26 | |||||
| ROA % | -104.5 | |||||
| ROIC % | -978.26 | |||||
| 3-Year ROIIC % | 74.77 | |||||
| ROC (Joel Greenblatt) % | -1245.93 | |||||
| ROCE % | -112 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.56 | |||||
| Price-to-Tangible-Book | 0.56 | |||||
| EV-to-EBIT | 0.28 | |||||
| EV-to-EBITDA | 0.28 | |||||
| EV-to-FCF | 0.22 | |||||
| Price-to-Net-Current-Asset-Value | 0.56 | |||||
| Price-to-Net-Cash | 0.65 | |||||
| Earnings Yield (Greenblatt) % | 357.14 | |||||
| FCF Yield % | -190.57 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:BBLG
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Bone Biologics Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -7.251 | ||
| Beta | 0.44 | ||
| Volatility % | 124.84 | ||
| 14-Day RSI | 43.82 | ||
| 14-Day ATR ($) | 0.11172 | ||
| 20-Day SMA ($) | 1.038025 | ||
| 12-1 Month Momentum % | -73.1 | ||
| 52-Week Range ($) | 0.8 - 4.79 | ||
| Shares Outstanding (Mil) | 2.46 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Bone Biologics Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Bone Biologics Corp Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Bone Biologics Corp Frequently Asked Questions
What is Bone Biologics Corp(BBLG)'s stock price today?
The current price of BBLG is $1.02. The 52 week high of BBLG is $4.79 and 52 week low is $0.80.
When is next earnings date of Bone Biologics Corp(BBLG)?
The next earnings date of Bone Biologics Corp(BBLG) is 2025-02-14 Est..
Does Bone Biologics Corp(BBLG) pay dividends? If so, how much?
Bone Biologics Corp(BBLG) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers